| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER |
Sell |
$62.59 |
27,421 |
$1,716,379 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$ALPAlpha Compute Corp |
Villani FiorenzoSee Remarks, Director |
Buy |
$4.07 |
10,382 |
$42,263 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$NTRANatera, Inc. |
Sheena JonathanDirector, CO-FOUNDER |
Sell |
$350.07 |
6,000 |
$2,100,431 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
ROTE WILLIAM E.Chief Research Officer |
Sell |
$65.31 |
270 |
$17,634 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
ROTE WILLIAM E.Chief Research Officer |
Sell |
$63.65 |
3,000 |
$190,952 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
ROTE WILLIAM E.Chief Research Officer |
Sell |
$62.66 |
29,021 |
$1,818,317 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
ROTE WILLIAM E.Chief Research Officer |
Sell |
$61.99 |
63,907 |
$3,961,851 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-18 |
$NTHINEONC TECHNOLOGIES HOLDINGS, INC. |
GARNETT KEITHLYCFO |
Sell |
$3.36 |
5,000 |
$16,809 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-18 |
$RWTREDWOOD TRUST INC |
Abate Christopher JChief Executive Officer, Director |
Buy |
$3.84 |
100,000 |
$383,900 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Dube Eric MCHIEF EXECUTIVE OFFICER, Director |
Sell |
$61.99 |
63,498 |
$3,936,527 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER |
Sell |
$62.05 |
71,938 |
$4,463,875 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Dube Eric MCHIEF EXECUTIVE OFFICER, Director |
Sell |
$63.64 |
3,102 |
$197,422 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$XBPXBP Global Holdings, Inc. |
CHADHA PARDirector |
Buy |
$2.83 |
204,946 |
$579,997 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Dube Eric MCHIEF EXECUTIVE OFFICER, Director |
Sell |
$65.31 |
270 |
$17,634 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$AAPLApple Inc. |
Newstead JenniferSVP, GC and Government Affairs |
Sell |
$330.19 |
1,438 |
$474,813 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$AMALAmalgamated Financial Corp. |
Searby SeanEVP Chief Info. & Ops. Officer |
Sell |
$47.75 |
3,314 |
$158,231 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$HAPNHappen, Inc. |
Selleck ErinDirector |
Sell |
$16.68 |
7,148 |
$119,229 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$ROIVRoivant Sciences Ltd. |
Fitzgerald MeghanDirector |
Sell |
$39.68 |
4,712 |
$186,972 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$ROIVRoivant Sciences Ltd. |
Epperly Melissa B,Director |
Sell |
$40.38 |
600 |
$24,228 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$XBPXBP Global Holdings, Inc. |
Jonovic AndrejChief Executive Officer, Director |
Buy |
$2.83 |
31,500 |
$89,145 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$XBPXBP Global Holdings, Inc. |
Avramovic DejanChief Financial Officer |
Buy |
$2.83 |
8,833 |
$24,997 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$ROIVRoivant Sciences Ltd. |
Fitzgerald MeghanDirector |
Sell |
$40.45 |
400 |
$16,180 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$ADPTAdaptive Biotechnologies Corp |
BOBULSKY SUSANChief Commercial Officer, MRD |
Sell |
$27.00 |
1,195 |
$32,265 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER |
Sell |
$62.85 |
800 |
$50,278 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER |
Sell |
$62.13 |
4,275 |
$265,627 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Cline Christopher R.CHIEF FINANCIAL OFFICER |
Sell |
$65.31 |
400 |
$26,124 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Cline Christopher R.CHIEF FINANCIAL OFFICER |
Sell |
$63.69 |
1,900 |
$121,004 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Cline Christopher R.CHIEF FINANCIAL OFFICER |
Sell |
$62.61 |
20,735 |
$1,298,175 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER |
Sell |
$63.66 |
300 |
$19,099 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Cline Christopher R.CHIEF FINANCIAL OFFICER |
Sell |
$62.00 |
27,473 |
$1,703,241 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$BLLNBillionToOne, Inc. |
Atay OguzhanChairman and CEO, Director |
Sell |
$98.00 |
2,666 |
$261,268 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$PVLAPALVELLA THERAPEUTICS, INC. |
JENKINS GEORGE MDirector |
Sell |
$152.12 |
6,160 |
$937,034 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$PVLAPALVELLA THERAPEUTICS, INC. |
JENKINS GEORGE MDirector |
Sell |
$151.46 |
5,632 |
$853,037 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$SNEXStoneX Group Inc. |
Maurer Mark LowryChief Risk Officer |
Sell |
$68.83 |
52,564 |
$3,617,864 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$MAXMediaAlpha, Inc. |
Nonko EugeneDirector |
Sell |
$11.96 |
7,778 |
$93,005 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$MAXMediaAlpha, Inc. |
Nonko EugeneDirector |
Sell |
$12.03 |
2,667 |
$32,095 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$BLLNBillionToOne, Inc. |
Atay OguzhanChairman and CEO, Director |
Sell |
$99.57 |
1,500 |
$149,352 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$BLLNBillionToOne, Inc. |
Atay OguzhanChairman and CEO, Director |
Sell |
$101.49 |
3,143 |
$318,989 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$BLLNBillionToOne, Inc. |
Atay OguzhanChairman and CEO, Director |
Sell |
$100.78 |
2,010 |
$202,559 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$BLLNBillionToOne, Inc. |
Atay OguzhanChairman and CEO, Director |
Sell |
$98.64 |
1,680 |
$165,708 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$DUOLDuolingo, Inc. |
Chen Stephen C.General Counsel |
Sell |
$147.43 |
2,107 |
$310,635 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-16 |
$BLLNBillionToOne, Inc. |
Atay OguzhanChairman and CEO, Director |
Sell |
$101.44 |
7,214 |
$731,793 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$PVLAPALVELLA THERAPEUTICS, INC. |
JENKINS GEORGE MDirector |
Sell |
$153.10 |
1,560 |
$238,834 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$WNCWABASH NATIONAL Corp |
Glazner Mary KristinChief Administrative Officer |
Sell |
$12.25 |
10,000 |
$122,500 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$DUOLDuolingo, Inc. |
Chen Stephen C.General Counsel |
Sell |
$150.00 |
5,965 |
$894,750 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$NETCloudflare, Inc. |
Ledbetter CarlDirector |
Sell |
$309.51 |
960 |
$297,126 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$NETCloudflare, Inc. |
Ledbetter CarlDirector |
Sell |
$310.54 |
440 |
$136,638 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$NETCloudflare, Inc. |
Ledbetter CarlDirector |
Sell |
$312.86 |
2,400 |
$750,864 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$NETCloudflare, Inc. |
Ledbetter CarlDirector |
Sell |
$313.71 |
1,200 |
$376,452 |
EDGAR Form 4 ↗ |
| 2026-09-14filed 2026-09-15 |
$IPSCCentury Therapeutics, Inc. |
Russotti GregorySee Remarks |
Sell |
$1.93 |
2,587 |
$4,993 |
EDGAR Form 4 ↗ |